Tablets & Capsules

TC0120

Issue link: https://www.e-digitaleditions.com/i/1199406

Contents of this Issue

Navigation

Page 57 of 67

48 January 2020 Tablets & Capsules supplier news Catalent, Ethicann to develop CBD treatment for MS spasticity SOM ER SE T, NJ — Catalent, a pharmaceutical CDMO, has part- nered with Ethicann Pharmaceuticals, a Calgary-based pharmaceutical com- pany, to develop a combination phar- maceutical-grade cannabidiol (CBD) and tetrahydrocannabinol (THC) product to treat patients suffering from multiple sclerosis (MS) spas- ticity. If approved, the product will use Catalent's Zydis orally disinte- grating tablet platform and Ethicann's botanically-sourced cannabinoid oils. The companies plan to work on other cannabinoid-based products in the future, including a combination of THC and CBD to treat chemother- apy-induced nausea and vomiting, chronic pain, post-traumatic stress disorder, and opioid mitigation. Hermes awarded metal for sustainability PULLACH, Germany—EcoVadis, an international rating agency, has awarded Hermes Pharma, a CDMO specializing in user-f riendly oral dosage forms, a silver medal for its commitment to cor porate social responsibility (CSR) and sustainabil- ity initiatives. The agency analyzes more than 45,000 companies in 190 industry sectors and 150 countries annually to assess how they integrate CSR principles into their business and management systems. Thermo Fisher expands API manufacturing capabilities CORK, Ireland— Thermo Fisher Scientific has acquired GlaxoSmith- K line's facilit y in Cork, Ireland, allowing the CDMO to expand its API manufacturing capabilities. The site's 400 employees will become part of Thermo Fisher's Pharma Ser- vices A PI business. T he CDMO will use the Cork team's expertise to develop novel synthetic processes and help customers scale up pro- duction from clinical development GCP Audits – Best Practices for Ensuring Compliance & Detecting Fraud and Misconduct in Clinical Trials. March 19-20 in Malvern, PA. Conducted by Center for Professional Innovation & Education (www.cfpie. com, 610 648 7550). DCAT Week. March 23-26 in New York, NY. Conducted by the Drug, Chemical, & Associated Technologies Association (www.dcatweek.org, 609 208 1888). Pharmaceutical GMP Audits and Self-Inspections. March 23-27 in Manchester, UK. Conducted by NSF (www.nsf.org, 734 769 8010). GMPs for OTC & Cosmetic Prod- ucts–US and Global Requirements. March 25-26 in Malvern, PA. Con- ducted by Center for Professional Innovation & Education (www.cfpie. com, 610 648 7550). ISPE Europe Annual Conference. March 30-April 2 in Madrid, Spain. Conducted by International Society for Pharmaceutical Engineers (www. ispe.org, 301 364 9201). Drug Delivery Partnerships. March 30-April 1 in Orlando, FL. Conducted by Informa (informaconnect.com / ddp/, 888 670 8200). Pharmaceutical Quality Systems-QP Module. March 30-April 2 in York, UK. Conducted by NSF (www.nsf. org, 734 769 8010). EyeforPharma March 31-Apr il 2 in Barcelona, Spain. Conducted by Reuters Events (www.eyeforpharma. com/barcelona, jmackintosh@eyefor pharma.com). Gravity Flow & Storage of Bulk Sol- ids. March 31-April 2 in Salina, KS. Conducted by K-State Bulk Solids Innovation Center. (www.bulk-solids. k-state.edu, 855 552 0079). Tablet Coating. March 31-April 2 in Binzen, Germany. Conducted by Technology Training Center (www. ttc-binzen.de, +49 7621 664 308). Formulation and Processing Part 2– QP Module. March 9-13 in London, UK. Conducted by NSF (www.nsf. org, 734 769 8010). Technical Writing for Pharma, Bio- tech and Med Devices. March 11-13 in Dublin, Ireland. Conducted by Center for Professional Innovation & Educa- tion (www.cfpie.com, 610 648 7550). Intro to Tablet Press Operations. March 12 in Cypress, CA. Conducted by Natoli Service Center (natoli.com, 636 926 8900). CPhI Japan. March 16-18 in Tokyo, Japan. Conducted by Informa (www. cphi.com/japan, +31 207 081 637). Pharmaceutical GMP Audits and Self-Inspections. March 16-20 in Ann Arbor, MI. Conducted by NSF (www. nsf.org, 734 769 8010). Pharmaceutical Legislation Update. March 17 in Manchester, UK. Con- ducted by NSF (www.nsf.org, 734 769 8010). Defects Resolution & Problem Solv- ing. March 17-19 in Cleveland, OH. Conducted by Techceuticals (www. techceuticals.com, 216 658 8038). Pharmaceutical GMP. March 17-19 in Amsterdam, Netherlands. Conducted by NSF (www.nsf.org, 734 769 8010). Regulatory Affairs for QA: Mar- keting Authorisations. March 18 in Manchester, UK. Conducted by NSF (www.nsf.org, 734 769 8010). Basics of Tablet Press Operations & Tooling. March 18-19 in Pilchowo, Poland. Conducted by Natoli Service Center (natoli.com, 636 926 8900). Pharmaceutical Legislation Update. March 19 in Amsterdam, Netherlands. Conducted by NSF (www.nsf.org, 734 769 8010). Regulatory Affairs for QA: Varia- tions. March 19 in Manchester, UK. Conducted by NSF (www.nsf.org, 734 769 8010). FDA Inspections–What Regulators Expect and How to Prepare. March 19-20 in Malvern, PA. Conducted by Center for Professional Innovation & Education (www.cfpie.com, 610 648 7550).

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0120